June 30 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N
* Janssen Inc says Health Canada has issued a notice of
compliance with conditions approving Darzalex
* Janssen Inc says Darzalex approved by Health Canada for
for treatment of multiple Myeloma
* Janssen Inc says product approved on condition that co
carries out confirmatory trials to verify clinical benefit of
Darzalex
Source text for Eikon: ID:nCNW036cQa
Further company coverage: JNJ.N
(Bengaluru Newsroom; +1 646 223 8780)